Epigallocatechin-gallate Modulates Chemotherapy-induced Apoptosis in Human Cholangiocarcinoma Cells

Overview

Journal Liver Int

Specialty Gastroenterology

Date 2009 Feb 20

PMID 19226332

Citations 21

Authors

Molly Lang

Roger Henson

Chiara Braconi

Tushar Patel

Affiliations

Soon will be listed here.

Abstract

Background: Green tea polyphenols are chemopreventive in several cancer models but their use as adjunctive therapeutic agents for cancer is unknown.

Aims: Cholangiocarcinomas respond poorly to chemotherapeutic agents and our aims were to assess the utility of green tea polyphenols as adjuncts to chemotherapy for cholangiocarcinoma.

Materials And Methods: We assessed the effect of purified green tea catechins on chemotherapy-induced apoptosis in KMCH, CC-LP-1 and Mz-ChA-1 human cholangiocarcinoma cells, and on chemosensitivity of Mz-ChA-1 cell xenografts in nude mice.

Results: Epigallocatechin-gallate (EGCG), but not the structurally related catechin epigallocatechin, sensitized cells to apoptosis induced by gemcitabine (GEM), mitomycin C or 5-fluorouracil in vitro. Mitochondrial membrane depolarization, cytosolic cytochrome c expression and apoptosis were increased in cells incubated with EGCG and GEM compared with either agent alone. Furthermore, EGCG decreased in vivo growth and increased the sensitivity to GEM of Mz-ChA-1 cell xenografts in nude mice.

Conclusions: The green tea polyphenol EGCG sensitizes human cholangiocarcinoma cells to chemotherapy-induced apoptosis and warrants evaluation as an adjunct to chemotherapy for the treatment of human cholangiocarcinoma.

Citing Articles

Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches.

Khosla D, Misra S, Chu P, Guan P, Nada R, Gupta R Cancers (Basel). 2024; 16(4).

PMID: 38398194 PMC: 10887007. DOI: 10.3390/cancers16040801.

Possible Beneficial Effects of Hydrolyzable Tannins Deriving from L. in Internal Medicine.

Marrone G, Di Lauro M, Izzo F, Cornali K, Masci C, Vita C Nutrients. 2024; 16(1).

PMID: 38201875 PMC: 10780656. DOI: 10.3390/nu16010045.

Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas.

Persano F, Gigli G, Leporatti S Int J Mol Sci. 2022; 23(6).

PMID: 35328780 PMC: 8955269. DOI: 10.3390/ijms23063360.

Evolution of the Experimental Models of Cholangiocarcinoma.

Massa A, Varamo C, Vita F, Tavolari S, Peraldo-Neia C, Brandi G Cancers (Basel). 2020; 12(8).

PMID: 32824407 PMC: 7463907. DOI: 10.3390/cancers12082308.

Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.

Almatroodi S, Almatroudi A, Khan A, Alhumaydhi F, Alsahli M, Rahmani A Molecules. 2020; 25(14).

PMID: 32660101 PMC: 7397003. DOI: 10.3390/molecules25143146.

References

Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salame E . Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol. 2005; 17(10):1135-7. DOI: 10.1097/00042737-200510000-00021. View

Lambert J, Yang C . Mechanisms of cancer prevention by tea constituents. J Nutr. 2003; 133(10):3262S-3267S. DOI: 10.1093/jn/133.10.3262S. View

Sartippour M, Shao Z, Heber D, Beatty P, Zhang L, Liu C . Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr. 2002; 132(8):2307-11. DOI: 10.1093/jn/132.8.2307. View

Bonkovsky H . Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med. 2006; 144(1):68-71. DOI: 10.7326/0003-4819-144-1-200601030-00020. View

Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H . Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study. Jpn J Clin Oncol. 2005; 35(2):68-73. DOI: 10.1093/jjco/hyi021. View

Yamagiwa Y, Meng F, Patel T . Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes. Life Sci. 2005; 78(21):2494-502. PMC: 1524874. DOI: 10.1016/j.lfs.2005.10.015. View

Chou T, Talalay P . Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984; 22:27-55. DOI: 10.1016/0065-2571(84)90007-4. View

Jimenez-Saenz M, Martinez-Sanchez M . Acute hepatitis associated with the use of green tea infusions. J Hepatol. 2006; 44(3):616-7. DOI: 10.1016/j.jhep.2005.11.041. View

Patel T . Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(1):33-42. DOI: 10.1038/ncpgasthep0389. View

10.

Balasubramanian S, Efimova T, Eckert R . Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem. 2001; 277(3):1828-36. DOI: 10.1074/jbc.M110376200. View

11.

Leone M, Zhai D, Sareth S, Kitada S, Reed J, Pellecchia M . Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003; 63(23):8118-21. View

12.

Mei Y, Qian F, Wei D, Liu J . Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol. 2004; 56(10):1307-14. DOI: 10.1211/0022357044364. View

13.

Andreadi C, Howells L, Atherfold P, Manson M . Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol. 2005; 69(3):1033-40. DOI: 10.1124/mol.105.018374. View

14.

Hong J, Lu H, Meng X, Ryu J, Hara Y, Yang C . Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002; 62(24):7241-6. View

15.

Blot W, Chow W, McLaughlin J . Tea and cancer: a review of the epidemiological evidence. Eur J Cancer Prev. 1996; 5(6):425-38. View

16.

Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H . Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 1998; 19(10):1771-6. DOI: 10.1093/carcin/19.10.1771. View

17.

Patel T . Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002; 2:10. PMC: 113759. DOI: 10.1186/1471-2407-2-10. View

18.

Lambert J, Lee M, Lu H, Meng X, Hong J, Seril D . Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr. 2003; 133(12):4172-7. DOI: 10.1093/jn/133.12.4172. View

19.

Breckenridge D, Xue D . Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol. 2004; 16(6):647-52. DOI: 10.1016/j.ceb.2004.09.009. View

20.

Patel T . Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; 33(6):1353-7. DOI: 10.1053/jhep.2001.25087. View